Cargando…
Barriers to treatment: describing them from a different perspective
BACKGROUND: Poor adherence is the result of many barriers. Most of the adherence research has focused on the patients’ hurdles to adherence, instead of the responsibility the physician has for assuring adherence to treatment. OBJECTIVE: The purpose of this review is to identify barriers to medicatio...
Autores principales: | Devine, Francesca, Edwards, Taylor, Feldman, Steven R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775743/ https://www.ncbi.nlm.nih.gov/pubmed/29398908 http://dx.doi.org/10.2147/PPA.S147420 |
Ejemplares similares
-
Kinetic isotope effects and how to describe them
por: Karandashev, Konstantin, et al.
Publicado: (2017) -
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
por: Scaglione, Francesco, et al.
Publicado: (2019) -
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023) -
Identification of barriers to insulin therapy and approaches to overcoming them
por: Russell‐Jones, David, et al.
Publicado: (2017) -
Confidence in Biosimilar Drugs is Not Much Improved by Framing Them as the “Gold” Alternative Treatment Option to Bio-originators
por: Hrin, Matthew L., et al.
Publicado: (2021)